Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults

Kyla M. Shea; Mary Cushman; Sarah L. Booth; Gregory L. Burke; Haiying Chen; Stephen B. Kritchevsky

doi:10.1160/TH13-12-1003

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2014; 112(03): 438-444
DOI: 10.1160/TH13-12-1003

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

Schattauer GmbH

Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults

The Multi-Ethnic Study of Atherosclerosis

Kyla M. Shea

¹USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, USA

,

Mary Cushman

²Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, USA

,

Sarah L. Booth

¹USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, USA

,

Gregory L. Burke

³Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA

,

Haiying Chen

³Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA

,

Stephen B. Kritchevsky

⁴Sticht Center on Aging, Wake Forest School of Medicine, Winston-Salem North Carolina, USA

› Institutsangaben

Abstract

Summary

Vitamin K is integral to haemostatic function, and in vitro and animal experiments suggest that vitamin K can suppress production of inflammatory cytokines. To test the hypothesis that higher vitamin K status is associated with lower haemostatic activation and inflammation in community-dwelling adults, we analysed the cross-sectional association between serum phylloquinone (vitamin K1) with haemostatic and inflammatory biomarkers in 662 participants in the Multi- Ethnic Study of Atherosclerosis (MESA) [mean (SD) age=62 (10) years; 46% female; 37% Caucasian, 25% African-American, 25% Hispanic, 13% Chinese-American]. Following adjustment for demographic and lifestyle characteristics, medication use, triglycerides and body mass index, those in the highest quartile of serum phylloquinone had significantly lower circulating interleukin-6 [adjusted mean (SEM) pmol/l: quartile 4 (Q4)=1.22 (0.07), quartile 1 (Q1)=1.45 (0.07); p-trend<0.01], C-reactive protein [adjusted mean (SEM) mg/dl: Q4=1.57 (0.11), Q1=2.08 (0.18); p-trend=0.02], soluble intercellular adhesion molecule-1 [adjusted mean (SEM) ng/ml: Q4=247 (11), Q1=288 (11); p-trend=0.02], and plasmin-antiplasmin complex [adjusted mean (SEM) nmol/l: Q4=4.02 (0.1), Q1=4.31 (0.1), p-trend=0.04]. We detected an interaction between age and serum phylloquinone with respect to factor VIII and D-dimer (interaction p-values=0.03 and 0.09, respectively). Among participants ≥70 years, serum phylloquinone was inversely associated with factor VIII activity (p-trend=0.06) and positively associated with D-dimer (p-trend=0.01), but was not associated with either marker among participants <70 years (both p≥0.38). In contrast, dietary phylloquinone intake was not associated with any inflammatory or haemostatic biomarker evaluated (all p-trend>0.11). These findings are consistent with laboratorybased studies that suggest a possible anti-inflammatory role for vitamin K. Whether or not these associations predict clinical outcomes linked to elevated inflammation or haemostatic activation remains to be determined.

Keywords

Haemostasis - inflammation - nutrition - epidemiological studies

Volltext

Referenzen

References
1 Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109 (21) Suppl II2-10.
2 Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol 2012; 32: 1771-1776.
3 Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009; 94: 3171-3182.
4 Kannel WB. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005; 40: 1215-1220.
5 Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA. et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 2009; 101 Suppl S1-45.
6 Neyestani TR, Nikooyeh B, Alavi-Majd H. et al. Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. J Clin Endocrinol Metab 2012; 97: 2005-2011.
7 Dunn-Lewis C, Kraemer WJ, Kupchak BR. et al. A multi-nutrient supplement reduced markers of inflammation and improved physical performance in active individuals of middle to older age: a randomized, double-blind, placebo-controlled study. Nutr J 2011; 10: 90.
8 Yiu YF, Yiu KH, Siu CW. et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013; 227: 140-146.
9 Ramos LF, Kane J, McMonagle E. et al. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. J Ren Nutr 2011; 21: 211-218.
10 McCann JC, Ames BN. Vitamin K an example of triage theory: is micronutrient inadequacy linked to diseases of aging?. Am J Clin Nutr 2009; 90: 889-907.
11 Booth SL, Pennington JA, Sadowski JA. Food sources and dietary intakes of vitamin K-1 (phylloquinone) in the American diet: data from the FDA Total Diet Study. J Am Diet Assoc 1996; 96: 149-154.
12 Ohsaki Y, Shirakawa H, Hiwatashi K. et al. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem 2006; 70: 926-932.
13 Ohsaki Y, Shirakawa H, Miura A. et al. Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor kappaB through the repression of IKKalpha/beta phosphorylation. J Nutr Biochem 2010; 21: 1120-1126.
14 Reddi K, Henderson B, Meghji S. et al. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine 1995; 07: 287-290.
15 Shea MK, Booth SL, Massaro JM. et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008; 167: 313-320.
16 Juanola-Falgarona M, Salas-Salvado J, Estruch R. et al. Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk. Cardiovasc Diabetol 2013; 12: 7.
17 Shea MK, Dallal GE, Dawson-Hughes B. et al. Vitamin K circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr 2008; 88: 356-363.
18 Bild DE, Bluemke DA, Burke GL. et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871-881.
19 Folsom AR, Delaney JA, Lutsey PL. et al. Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. Am J Hematol 2009; 84: 349-353.
20 Roy B, Diez-Roux AV, Seeman T. et al. Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA). Psychosom Med 2010; 72: 134-140.
21 Davidson KW, Sadowski JA. Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection. Methods Enzymol 1997; 282: 408-421.
22 Nettleton JA, Rock CL, Wang Y. et al. Associations between dietary macronutrient intake and plasma lipids demonstrate criterion performance of the Multi-Ethnic Study of Atherosclerosis (MESA) food-frequency questionnaire. Br J Nutr 2009; 102: 1220-1227.
23 Nettleton JA, Steffen LM, Mayer-Davis EJ. et al. Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2006; 83: 1369-1379.
24 McKeown NM, Rasmussen HM, Charnley JM. et al. Accuracy of phylloquinone (vitamin K-1) data in 2 nutrient databases as determined by direct laboratory analysis of diets. J Am Diet Assoc 2000; 100: 1201-1204.
25 He K, Liu K, Daviglus ML. et al. Associations of dietary long-chain n-3 polyun-saturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 2009; 103: 1238-1243.
26 Nettleton JA, Schulze MB, Jiang R. et al. A priori-defined dietary patterns and markers of cardiovascular disease risk in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2008; 88: 185-194.
27 Bild DE, Detrano R, Peterson D. et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005; 111: 1313-1320.
28 Bertoni AG, Whitt-Glover MC, Chung H. et al. The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2009; 169: 444-454.
29 Lamon-Fava S, Sadowski JA, Davidson KW. et al. Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am J Clin Nutr 1998; 67: 1226-1231.
30 Shea MK, Booth SL, Nettleton JA. et al. Circulating phylloquinone concentrations of adults in the United States differ according to race and ethnicity. J Nutr 2012; 142: 1060-1066.
31 Manson JE, Bassuk SS, Lee IM. et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012; 33: 159-171.
32 Booth SL, Dallal G, Shea MK. et al. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 2008; 93: 1217-1223.
33 Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol 2001; 115: 3-12.
34 Schuett H, Luchtefeld M, Grothusen C. et al. How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost 2009; 102: 215-222.
35 Van der Heiden K, Cuhlmann S, Luong lA. et al. Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci 2010; 118: 593-605.
36 Tabb MM, Sun A, Zhou C. et al. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 2003; 278: 43919-43927.
37 Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15: 254-259.
38 Cushman M, Lemaitre RN, Kuller LH. et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 493-498.
39 Sakkinen PA, Cushman M, Psaty BM. et al. Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women. Arterioscler Thromb Vasc Biol 1999; 19: 499-504.
40 Sakkinen PA, Wahl P, Cushman M. et al. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000; 152: 897-907.
41 Cushman M, Folsom AR, Wang L. et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2003; 101: 1243-1248.
42 McKeown NM, Jacques PF, Gundberg CM. et al. Dietary and nondietary determinants of vitamin K biochemical measures in men and women. J Nutr 2002; 132: 1329-1334.
43 Veeranna V, Zalawadiya SK, Niraj A. et al. Association of novel biomarkers with future cardiovascular events is influenced by ethnicity: Results from a multi-ethnic cohort. Int J Cardiol 2013; 66: 487-493.

Zusatzmaterial

Zusatzmaterial